This methodology demonstrates solvent-controlled asymmetric hydrogenation in bisquinolines, highlighting enantioselectivity implications.
We report the first solvent-controlled chemoselective asymmetric hydrogenation of 2,8'-bisquinolines using chiral Ru/N-sulfonylated diamine complexes. By simply switching the solvent from dichloromethane to methanol, either chiral 1',2',3',4'-tetrahydrobisquinolines or 1,1',2,2',3,3',4,4'-octahydrobisquinolines were obtained in high yields with excellent enantioselectivities. The methodology was successfully applied to scale-up syntheses and the preparation of a new C₁-symmetric N-heterocyclic carbene ligand. Preliminary mechanistic study revealed that an intramolecular hydrogen bond in the tetrahydroquinoline intermediate is the key factor governing the chemoselectivity, which can be disrupted in protic solvents.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: